Join our free monthly roundtable webinars to dive into interactive discussions on the latest coding challenges and innovative solutions.
Round Table 166: Strategies for Coding Toe and Foot Amputations
January 23, 12pm ET
https://t.co/gij6BOtFLw
#medicalcoding
How does Datavant help life science companies achieve maximum commercial growth? By integrating first-party, specialty pharmacy, and third-party data we provide your team with valuable insights.
https://t.co/ZwYSJVNmCo
#datalogistics#pharma#healthcareinnovation
Turn up the volume with Datavant at @RISE National 2024!
Join us on Monday, March 18th, for an evening of networking at a #Nashville honky tonk. Space is limited - reserve your spot now!: https://t.co/5eUmV5KQhL
#RISENational2024#MedicareAdvantage#datalogistics
Datavant is thrilled to announce the launch of our Patient-Authorized Workflows for Clinical Trials. These workflows allow sponsors to link identifiable real-world health data for use in clinical research:
https://t.co/QxbUk89wFs
#clinicaltrials#healthcareinnovation
Looking for some light holiday reading on the topics of machine learning and identity resolution?
ICYMI: Our deep-dive on referential data was the most-read article of 2023 on Datavant's Tech Blog.
https://t.co/IntnmQwayS
#machinelearning#healthtech
As 2023 winds down and we reflect on what data logistics looked like for us this year, we want to say THANK YOU to all of our partners who have joined Datavant in our mission to build a better data supply chain for healthcare.
#datalogistics#partnership#healthcareinnovation
"How do we ensure that if these new AI models are using healthcare data as training or fine tuning elements of the model, that we still maintain privacy?" @vera_mucaj featured on the Data in Biotech Podcast.
Apple: https://t.co/BdFIH3rXrh
#healthcareinnovation#ai#biotech
We're proud to announce that Datavant is the first data logistics organization to earn Validated Data Stream status through the @ncqa Data Aggregator Validation program. https://t.co/sjXtNlmygc
#NCQA#HEDIS
Substance misuse is a complex and multifaceted problem. Datavant was proud to contribute PPRL to the establishment of the Substance Misuse Data Commons (SMDC).
Read more about the creation of the SMDC:
https://t.co/cQHcyPqdQz
#healthcareinnovation#datalogistics#healthdata
"AI will not work without high-quality multimodal data."
We spoke with @MirunaSasu, CEO at COTA, about the value of combining data of various types to accelerate oncology research, build better AI models, and more.
https://t.co/g41ao7voPJ
#oncology#ai#healthcareinnovation
"We are amid a data revolution, with petabytes of available data. Yet, we are unable to engage with sensitive data to do basic activities..."
Check out this @JAMA_current article on tokenization by @KShah0520@dapattmd@SamyuktaMD
https://t.co/HL191huuAs
#HealthTech#Tokenization
"RWD and anonymized patient-level data is creating groundbreaking capabilities and projects that have been trying to accelerate the path to diagnosis..." - Steve Davenport, on our most recent webinar with @McKesson@TakedaPharma@DukeHealth.
https://t.co/aXTyA8DQmM
#healthdata
Read the newly published research paper on using Datavant's (PPRL) tools to pilot a digital platform that builds a holistic patient picture with patient-level and community-level de-identified #sdoh data
Learn more https://t.co/GPbKz0IdH8
#Healthcareinnovation#populationhealth
Join our Clinical Trials Scientific Lead Kathleen Gavin in a webinar on Dec 6th, hosted by ISPOR 'Tokenization in Clinical Trials: Benefits and End-to-End Enablement'
Register here - https://t.co/4tdrKiyckF
#tokenization#clinicaltrials#healthdata
"By linking mortality data to clinical RWD, researchers can...build more accurate survival curves, measure mortality as an endpoint in HEOR studies, and better build synthetic control arms for interventional clinical trials." Jason LaBonte CEO of Veritas
https://t.co/Hx1cQJxOav
Datavant customers can now gain access to @@stataratweets's rich consumer data and social determinants of health so that they can de-identify and compliantly link datasets to Statara’s data at the individual level.
Read about it here: https://t.co/vtYdSLxBuD
"Pathology data has long played a vital role in the diagnosis of cancer and other diseases, informing up to 70% of clinical decisions." Check out our conversation with Ross Cantor, VP Data Strategy & Partnerships at @ProsciaInc
https://t.co/amL6QIy3kz
#pathology#drugdiscovery